Diagnostic pathways and direct medical costs incurred by new adult pulmonary tuberculosis patients prior to anti-tuberculosis treatment - Tamil Nadu, India.
Tuberculosis (TB) patients face substantial delays prior to treatment initiation, and out of pocket (OOP) expenditures often surpass the economic productivity of the household. We evaluated the pre-diagnostic cost and health seeking behaviour of new adult pulmonary TB patients registered at Primary...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5802859?pdf=render |
id |
doaj-70d15138b37e4a3e8191019e602e08d0 |
---|---|
record_format |
Article |
spelling |
doaj-70d15138b37e4a3e8191019e602e08d02020-11-25T00:51:39ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-01132e019159110.1371/journal.pone.0191591Diagnostic pathways and direct medical costs incurred by new adult pulmonary tuberculosis patients prior to anti-tuberculosis treatment - Tamil Nadu, India.Karun Sandeep VeesaKamalabhai Russell JohnPatrick K MoonanSaravanakumar Puthupalayam KaliappanKrishna ManjunathKaruna D SagiliChinnappareddy RavichandraPradeep Aravindan MenonChandrakumar DollaNancy LukeKaivan MunshiKuryan GeorgeShantidani MinzTuberculosis (TB) patients face substantial delays prior to treatment initiation, and out of pocket (OOP) expenditures often surpass the economic productivity of the household. We evaluated the pre-diagnostic cost and health seeking behaviour of new adult pulmonary TB patients registered at Primary Health Centres (PHCs) in Vellore district, Tamil Nadu, India.This descriptive study, part of a randomised controlled trial conducted in three rural Tuberculosis Units from Dec 2012 to Dec 2015, collected data on number of health facilities, dates of visits prior to the initiation of anti-tuberculosis treatment, and direct OOP medical costs associated with TB diagnosis. Logistic regression analysis examined the factors associated with delays in treatment initiation and OOP expenditures.Of 880 TB patients interviewed, 34.7% presented to public health facilities and 65% patients sought private health facilities as their first point of care. The average monthly individual income was $77.79 (SD 57.14). About 69% incurred some pre-treatment costs at an average of $39.74. Overall, patients experienced a median of 6 days (3-11 IQR) of time to treatment initiation and 21 days (10-30 IQR) of health systems delay. Age ≤ 40 years (aOR: 1.73; CI: 1.22-2.44), diabetes (aOR: 1.63; CI: 1.08-2.44) and first visit to a private health facility (aOR: 17.2; CI: 11.1-26.4) were associated with higher direct OOP medical costs, while age ≤ 40 years (aOR: 0.64; CI: 0.48-0.85) and first visit to private health facility (aOR: 1.79, CI: 1.34-2.39) were associated with health systems delay.The majority of rural TB patients registering at PHCs visited private health facilities first and incurred substantial direct OOP medical costs and delays prior to diagnosis and anti-tuberculosis treatment initiation. This study highlights the need for PHCs to be made as the preferred choice for first point of contact, to combat TB more efficiently.http://europepmc.org/articles/PMC5802859?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Karun Sandeep Veesa Kamalabhai Russell John Patrick K Moonan Saravanakumar Puthupalayam Kaliappan Krishna Manjunath Karuna D Sagili Chinnappareddy Ravichandra Pradeep Aravindan Menon Chandrakumar Dolla Nancy Luke Kaivan Munshi Kuryan George Shantidani Minz |
spellingShingle |
Karun Sandeep Veesa Kamalabhai Russell John Patrick K Moonan Saravanakumar Puthupalayam Kaliappan Krishna Manjunath Karuna D Sagili Chinnappareddy Ravichandra Pradeep Aravindan Menon Chandrakumar Dolla Nancy Luke Kaivan Munshi Kuryan George Shantidani Minz Diagnostic pathways and direct medical costs incurred by new adult pulmonary tuberculosis patients prior to anti-tuberculosis treatment - Tamil Nadu, India. PLoS ONE |
author_facet |
Karun Sandeep Veesa Kamalabhai Russell John Patrick K Moonan Saravanakumar Puthupalayam Kaliappan Krishna Manjunath Karuna D Sagili Chinnappareddy Ravichandra Pradeep Aravindan Menon Chandrakumar Dolla Nancy Luke Kaivan Munshi Kuryan George Shantidani Minz |
author_sort |
Karun Sandeep Veesa |
title |
Diagnostic pathways and direct medical costs incurred by new adult pulmonary tuberculosis patients prior to anti-tuberculosis treatment - Tamil Nadu, India. |
title_short |
Diagnostic pathways and direct medical costs incurred by new adult pulmonary tuberculosis patients prior to anti-tuberculosis treatment - Tamil Nadu, India. |
title_full |
Diagnostic pathways and direct medical costs incurred by new adult pulmonary tuberculosis patients prior to anti-tuberculosis treatment - Tamil Nadu, India. |
title_fullStr |
Diagnostic pathways and direct medical costs incurred by new adult pulmonary tuberculosis patients prior to anti-tuberculosis treatment - Tamil Nadu, India. |
title_full_unstemmed |
Diagnostic pathways and direct medical costs incurred by new adult pulmonary tuberculosis patients prior to anti-tuberculosis treatment - Tamil Nadu, India. |
title_sort |
diagnostic pathways and direct medical costs incurred by new adult pulmonary tuberculosis patients prior to anti-tuberculosis treatment - tamil nadu, india. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2018-01-01 |
description |
Tuberculosis (TB) patients face substantial delays prior to treatment initiation, and out of pocket (OOP) expenditures often surpass the economic productivity of the household. We evaluated the pre-diagnostic cost and health seeking behaviour of new adult pulmonary TB patients registered at Primary Health Centres (PHCs) in Vellore district, Tamil Nadu, India.This descriptive study, part of a randomised controlled trial conducted in three rural Tuberculosis Units from Dec 2012 to Dec 2015, collected data on number of health facilities, dates of visits prior to the initiation of anti-tuberculosis treatment, and direct OOP medical costs associated with TB diagnosis. Logistic regression analysis examined the factors associated with delays in treatment initiation and OOP expenditures.Of 880 TB patients interviewed, 34.7% presented to public health facilities and 65% patients sought private health facilities as their first point of care. The average monthly individual income was $77.79 (SD 57.14). About 69% incurred some pre-treatment costs at an average of $39.74. Overall, patients experienced a median of 6 days (3-11 IQR) of time to treatment initiation and 21 days (10-30 IQR) of health systems delay. Age ≤ 40 years (aOR: 1.73; CI: 1.22-2.44), diabetes (aOR: 1.63; CI: 1.08-2.44) and first visit to a private health facility (aOR: 17.2; CI: 11.1-26.4) were associated with higher direct OOP medical costs, while age ≤ 40 years (aOR: 0.64; CI: 0.48-0.85) and first visit to private health facility (aOR: 1.79, CI: 1.34-2.39) were associated with health systems delay.The majority of rural TB patients registering at PHCs visited private health facilities first and incurred substantial direct OOP medical costs and delays prior to diagnosis and anti-tuberculosis treatment initiation. This study highlights the need for PHCs to be made as the preferred choice for first point of contact, to combat TB more efficiently. |
url |
http://europepmc.org/articles/PMC5802859?pdf=render |
work_keys_str_mv |
AT karunsandeepveesa diagnosticpathwaysanddirectmedicalcostsincurredbynewadultpulmonarytuberculosispatientspriortoantituberculosistreatmenttamilnaduindia AT kamalabhairusselljohn diagnosticpathwaysanddirectmedicalcostsincurredbynewadultpulmonarytuberculosispatientspriortoantituberculosistreatmenttamilnaduindia AT patrickkmoonan diagnosticpathwaysanddirectmedicalcostsincurredbynewadultpulmonarytuberculosispatientspriortoantituberculosistreatmenttamilnaduindia AT saravanakumarputhupalayamkaliappan diagnosticpathwaysanddirectmedicalcostsincurredbynewadultpulmonarytuberculosispatientspriortoantituberculosistreatmenttamilnaduindia AT krishnamanjunath diagnosticpathwaysanddirectmedicalcostsincurredbynewadultpulmonarytuberculosispatientspriortoantituberculosistreatmenttamilnaduindia AT karunadsagili diagnosticpathwaysanddirectmedicalcostsincurredbynewadultpulmonarytuberculosispatientspriortoantituberculosistreatmenttamilnaduindia AT chinnappareddyravichandra diagnosticpathwaysanddirectmedicalcostsincurredbynewadultpulmonarytuberculosispatientspriortoantituberculosistreatmenttamilnaduindia AT pradeeparavindanmenon diagnosticpathwaysanddirectmedicalcostsincurredbynewadultpulmonarytuberculosispatientspriortoantituberculosistreatmenttamilnaduindia AT chandrakumardolla diagnosticpathwaysanddirectmedicalcostsincurredbynewadultpulmonarytuberculosispatientspriortoantituberculosistreatmenttamilnaduindia AT nancyluke diagnosticpathwaysanddirectmedicalcostsincurredbynewadultpulmonarytuberculosispatientspriortoantituberculosistreatmenttamilnaduindia AT kaivanmunshi diagnosticpathwaysanddirectmedicalcostsincurredbynewadultpulmonarytuberculosispatientspriortoantituberculosistreatmenttamilnaduindia AT kuryangeorge diagnosticpathwaysanddirectmedicalcostsincurredbynewadultpulmonarytuberculosispatientspriortoantituberculosistreatmenttamilnaduindia AT shantidaniminz diagnosticpathwaysanddirectmedicalcostsincurredbynewadultpulmonarytuberculosispatientspriortoantituberculosistreatmenttamilnaduindia |
_version_ |
1725244643079094272 |